Literature DB >> 18242269

Predictors affecting durability of epicardial pacemaker leads in pediatric patients.

Hiroomi Murayama1, Masanobu Maeda, Hajime Sakurai, Akihiko Usui, Yuichi Ueda.   

Abstract

OBJECTIVES: Despite pacemaker therapy in children and adolescents favoring an initial epicardial approach, predictors of lead failure have not been well clarified. The aim of this study was to assess the long-term outcomes and to determine predictors affecting lead durability in pediatric pacing therapy.
METHODS: We reviewed the outcomes of 109 consecutive pacing leads implanted in 55 patients (median age, 5.2 years; range, 31 days-15.8 years), including 38 atrial and 71 ventricular leads. They consisted of 58 (53%) fishhooks, 37 (34%) screw-in leads, and 14 (13%) steroid-eluting suture-on leads. Seventy (64%) were implanted in patients with structural heart disease.
RESULTS: The leads were followed for a median of 6.4 years (range, 3 days-22.9 years). Lead failure occurred in 29 leads (27%; median of 8.4 years after implantation). Exit block or elevation of pacing threshold was the most common cause (n = 18), but failures did not directly cause patient death. The overall 1-, 5-, 10-, and 15-year lead survivals were 100%, 89.0%, 72.5%, and 55.5%, respectively. Multivariate Cox analysis revealed concurrent structural heart disease (relative risk, 2.85; 95% confidence interval, 1.27-6.42; P = .011) to be the only significant predictor of lead failure.
CONCLUSIONS: Epicardial leads provide a reliable technique for managing rhythmic disturbance problems in the pediatric population. The only significant predictor of lead failure is the presence of structural heart disease.

Entities:  

Mesh:

Year:  2008        PMID: 18242269     DOI: 10.1016/j.jtcvs.2007.09.002

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  11 in total

1.  Durability of repaired pacemaker leads in the pediatric population.

Authors:  Sarah Chambers; Alex Rusanov; Henry M Spotnitz; Eric S Silver; Leonardo Liberman
Journal:  J Interv Card Electrophysiol       Date:  2011-02-16       Impact factor: 1.900

Review 2.  Tricuspid valve incompetence following implantation of ventricular leads.

Authors:  Giselle A Baquero; Jerry Luck; Gerald V Naccarelli; Mario D Gonzalez; Javier E Banchs
Journal:  Curr Heart Fail Rep       Date:  2015-04

3.  Failure of epicardial pacing leads in congenital heart disease: not uncommon and difficult to predict.

Authors:  M C Post; W Budts; A Van de Bruaene; R Willems; B Meyns; F Rega; M Gewillig
Journal:  Neth Heart J       Date:  2011-08       Impact factor: 2.380

Review 4.  Resynchronization Therapy for Patients with Congenital Heart Disease: Are We Ready for Prime Time?

Authors:  Scott Anjewierden; Peter F Aziz
Journal:  Curr Cardiol Rep       Date:  2018-07-18       Impact factor: 2.931

5.  Permanent epicardial pacing in neonates and infants less than 1 year old: 12-year experience at a single center.

Authors:  Junfei Zhao; Ying Huang; Liming Lei; Zeyang Yao; Tian Liu; Hailong Qiu; Canhui Lin; Xiaobing Liu; Yun Teng; Xiaohua Li; Yong Zhang; Jian Zhuang; Jimei Chen; Shusheng Wen
Journal:  Transl Pediatr       Date:  2022-06

Review 6.  Pacing device therapy in infants and children: a review.

Authors:  Daiji Takeuchi; Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2012-10-27       Impact factor: 1.731

7.  The association between HERG gene expression and cardiac arrhythmia disease in children.

Authors:  Mingyu Fu; Chunli Li; Qingwen Wang; Yan Wang; Xinjiang An
Journal:  Exp Ther Med       Date:  2016-10-12       Impact factor: 2.447

8.  Minimally Invasive Epicardial Pacemaker Implantation in Neonates with Congenital Heart Block.

Authors:  Roberto Costa; Katia Regina da Silva; Martino Martinelli Filho; Roger Carrillo
Journal:  Arq Bras Cardiol       Date:  2017-09-04       Impact factor: 2.000

9.  A Cautionary Tale on Atrial Capture Management, Biventricular Pacing, and Recurrent Asystole.

Authors:  Christopher L Johnsrude; Kelvin C Lau
Journal:  J Innov Card Rhythm Manag       Date:  2019-10-15

10.  Performance of steroid eluting bipolar epicardial leads in pediatric and congenital heart disease patients: 15 years of single center experience.

Authors:  Christian Paech; Martin Kostelka; Ingo Dähnert; Patrick Flosdorff; Frank Thomas Riede; Roman Antonin Gebauer
Journal:  J Cardiothorac Surg       Date:  2014-05-12       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.